<ѻý>IBD Rates Low in Patients on Cosentyxѻý> Analysis of data from 21 clinical trials in psoriasis, psoriatic arthritis, and ankylosing spondylitis Jan 25, 2019
<ѻý>Targeting IL-1 Fails in Knee OAѻý> Little benefit seen for lutikizumab on scores for pain and function Jan 23, 2019
<ѻý>Combo Biologics in RA? Be Cautiousѻý> Risk of adverse events appeared to be less with tapered doses Dec 27, 2018
<ѻý>Cancer Treatment and Arthritis: A Growing Complaintѻý> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻý>Infection Risk Lower With Orencia vs Anti-TNFѻý> Increased risk for hospitalized infection with TNF inhibitors was driven largely by infliximab Dec 26, 2018
<ѻý>Good News for Pregnant Women With Psoriatic Arthritisѻý> No adverse effect on birth outcomes, and many reported fewer joint symptoms during pregnancy Dec 22, 2018
<ѻý>IL-1 Blocker Fails for Hand Osteoarthritisѻý> Pain, function, and structural changes were similar to placebo Dec 20, 2018
<ѻý>ACR: Can Tanezumab Be Revived for OA?ѻý> Low incidence of rapidly progressive OA seen with lower doses Oct 26, 2018
<ѻý>In Psoriatic Arthritis, Doubling Down on IL-17ѻý> Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
<ѻý>RA Guideline Adherence Spotty, Study Findsѻý> Treat-to-target recommendation not followed for half of patients Oct 23, 2018
<ѻý>New JAK1 Agent Beats Humira in Rheumatoid Arthritisѻý> Thrombotic events balanced between upadacitinib, adalimumab, and placebo Oct 22, 2018
<ѻý>Understanding Neuropathic-Like Knee Painѻý> Central risk factors may contribute to the condition, study shows Oct 13, 2018
<ѻý>Nurses Can Lead the Way in Researchѻý> ACR and EULAR studies demonstrated that research "is an important part of what we do" Aug 11, 2018
<ѻý>Minimal Disease Activity: The Goal in PsAѻý> Validity confirmed in large population of patients Jul 19, 2018
<ѻý>Enthesitis in PsA: A New Focus of Treatment?ѻý> Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
<ѻý>Cardiovascular Risk in RA: Beyond Inflammation?ѻý> With adverse lifestyle plus bad genes plus inflammation, 'you unleash hell' Jun 16, 2018
<ѻý>Weight, Smoking Inhibit RA Remissionѻý> Factors differ for women and men, but both relate to lifestyle Jun 15, 2018
<ѻý>Meds Improve Cardiovascular Risk in RAѻý> Benefits seen for hydroxychloroquine, methotrexate, and tocilizumab Jun 15, 2018
<ѻý>Inflammatory Eye Disease: Complex, Scaryѻý> Often related to autoimmune, inflammatory diseases May 10, 2018
<ѻý>RA Therapy: After Methotrexate, Then What?ѻý> Strong preference for anti-TNF therapy despite emerging data May 09, 2018
<ѻý>Tocilizumab Beats Anti-TNFs for Treatment Retentionѻý> Longer time on treatment, regardless of additional DMARDs May 08, 2018
<ѻý>RA Patients Pose Perioperative Challengesѻý> Expert discusses risk evaluation, stopping antirheumatic drugs May 07, 2018
<ѻý>Biosimilar Switch Succeeds in Single Centerѻý> Disease activity scores improved significantly after the change in rheumatoid arthritis patients May 04, 2018
<ѻý>4-Year Data in PsA Reassuring for Apremilastѻý> Benefits persist for joints and skin May 02, 2018
<ѻý>Adalimumab Clears Nail Disease in Psoriatic Arthritisѻý> Nail involvement often overlooked May 02, 2018
<ѻý>Shocker! Is Vioxx Coming Back... as an Orphan Drug?ѻý> Milton Packer wonders whether its return represents innovation or opportunism May 02, 2018
<ѻý>Troponin Predicts Mortality in Inflammatory Arthritisѻý> High levels associated with all-cause and cardiovascular death May 01, 2018
<ѻý>FDA Panel Gives Celecoxib Positive CV Safety Gradeѻý> Votes 15-5 that it is non-inferior to naproxen, ibuprofen Apr 25, 2018
<ѻý>Respect the Needle in OAѻý> Patients may be experiencing placebo effect, but it's still an effect, rheumatologist says Apr 19, 2018
<ѻý>Young Arthritis Patients Fare Worse on MTXѻý> High disease activity also linked with drug failure Mar 23, 2018
<ѻý>Novel Tx Eases Osteoarthritic Knee Painѻý> Geniculate artery embolization promising for knee pain, stiffness Mar 18, 2018
<ѻý>Death Strikes Young in RAѻý> Most common causes were circulatory, respiratory, and malignancy Mar 07, 2018
<ѻý>One Gout Medication Comes Out on Top for CV Riskѻý> Allopurinol the loser in retrospective comparison of two drugs Feb 26, 2018
<ѻý>Cancer Risk Stable in Kids on Anti-TNFsѻý> But background risks higher than in the general population Feb 20, 2018
<ѻý>Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trialѻý> Risankizumab broadly effective against joint and skin symptoms Nov 09, 2017
<ѻý>ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologicsѻý> Selections from late-breaker poster presentations at rheumatology meeting Nov 08, 2017
<ѻý>Biologics During Pregnancy Don't Raise Infection Risk for Infantsѻý> Gestational timing of exposure to biologic not an issue Nov 07, 2017
<ѻý>Lipid Changes with Sirukumab Called 'Anti-Atherogenic'ѻý> Looking for silver-lining in cloudy trial data Nov 06, 2017